Semi-Annual Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7738854

Concept 2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2015-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-45,047,000 JPY
-40,410,000 JPY
-73,423,000 JPY
-150,823,000 JPY
Depreciation
53,245,000 JPY
61,462,000 JPY
Increase (decrease) in allowance for doubtful accounts
JPY
-10,000 JPY
Interest and dividend income
-906,000 JPY
-1,890,000 JPY
Interest expenses
377,000 JPY
1,075,000 JPY
Foreign exchange losses (gains)
-2,630,000 JPY
4,817,000 JPY
Decrease (increase) in trade receivables
-14,415,000 JPY
-48,565,000 JPY
Decrease (increase) in inventories
3,040,000 JPY
-13,873,000 JPY
Increase (decrease) in trade payables
4,000 JPY
-6,625,000 JPY
Other, net
28,077,000 JPY
2,226,000 JPY
Subtotal
42,493,000 JPY
-66,870,000 JPY
Interest and dividends received
1,805,000 JPY
2,269,000 JPY
Interest paid
-354,000 JPY
-1,049,000 JPY
Income taxes paid
-2,532,000 JPY
-696,000 JPY
Net cash provided by (used in) operating activities
45,199,000 JPY
-58,028,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-31,603,000 JPY
-18,072,000 JPY
Purchase of investment securities
JPY
-102,793,000 JPY
Other, net
792,000 JPY
-2,871,000 JPY
Net cash provided by (used in) investing activities
-34,205,000 JPY
-124,423,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-14,420,000 JPY
-17,040,000 JPY
Proceeds from issuance of shares
382,685,000 JPY
8,544,000 JPY
Net cash provided by (used in) financing activities
354,660,000 JPY
-28,028,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,164,000 JPY
-185,000 JPY
Net increase (decrease) in cash and cash equivalents
367,819,000 JPY
-210,666,000 JPY
Cash and cash equivalents
1,620,341,000 JPY
1,252,522,000 JPY
1,463,188,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.